Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis®, a suite of artificial intelligence (AI)-powered Software as Medical Devices (SaMDs) for early cancer ...

As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...

Benefits include reduced radiation exposure, fewer adverse reactions, higher image quality, and better detection of malignant features.

We believe in screening so deeply because psychologically, we still believe that cancer is automatically a death sentence, ...

EVERY day without a dedicated PhilHealth Z Benefit Package for lung cancer means more Filipino families face delayed ...

The Lung Cancer Diagnostics Market is set to expand from US$ 21.74 billion in 2025 to US$ 38.00 billion by 2033, growing at a ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Patient advocates are calling for the immediate creation of a dedicated PhilHealth Z Benefit Package for lung cancer, warning that the absence of ...

Tempus AI (NasdaqGS:TEM) has launched a new AI-driven HRD-RNA algorithm aimed at improving cancer diagnostics. The company has entered a partnership with Median Technologies to bring advanced lung ...

Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the ...

Content by Froedtert South. Learn how Froedtert Pleasant Prairie Hospital utilizes innovative technology to deliver faster, more effective lung cancer care.